Sp443
EXPLORING MICROBIOME WITH MULTIFACETED EXPERTS: LIVER DISEASE, INFECTIOUS DISEASES, METABOLIC DISORDERS AND DIABETES AND CLINICAL TRIALS
Date
May 19, 2024
Presenters
University of Pittsburgh School of Medicine
Mayo Clinic
Tracks
Related Products
RE-CELLULARIZATION VIA ELECTROPORATION THERAPY (RECET) COMBINED WITH GLP-1RA TO REPLACE INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES 6 MONTHS RESULTS OF THE EMINENT STUDY
Non-variceal upper gastrointestinal bleeding (NVUGIB) accounts for a significant number of patient visits to emergency rooms and remains a major cause of mortality and morbidity worldwide. The re-bleeding rates of NVUGIB after endoscopic treatment within 72 hours have been reported to be up to 25%…